[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627653":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":41,"responsibleParty":63,"collaborators":26,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":26,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":26,"enrollmentInfo":75,"targetDuration":26,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":43,"whyStopped":26,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Bangladesh Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group P","ACTIVE_COMPARATOR","Pregabalin for diabetic peripheral neuropathic pain",[13],"Drug: Pregabalin",{"label":15,"type":16,"description":17,"interventionNames":18},"Group M","EXPERIMENTAL","Mirogabalin in Neuropathic Pain",[19],"Drug: Mirogabalin",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Mirogabalin","Mirogabalin in diabetic peripheral neuropathic pain",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Pregabalin","Pregabalin in diabetic peripheral neuropathic pain",[9],[32],{"name":33,"affiliation":5,"role":34},"AKM Akhtaruzzaman, MD","STUDY_DIRECTOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Kazi Mahzabin Arin, MD","CONTACT","+8801754057689","kazimahzabinarin@bsmmu.edu.bd",[42],{"facility":5,"status":43,"city":44,"state":26,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Dhaka","1000","Bangladesh","BD",{"type":49,"coordinates":50},"Point",[51,52],90.40744,23.7104,{"lat":52,"lon":51},[55,59,60],{"name":56,"role":38,"phone":57,"phoneExt":26,"email":58},"AKM Mahzabin Akhtaruzzaman, MD","+8801819220195","akm.akhtaruzzaman@bmu.ac.bd",{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},{"name":61,"role":62,"phone":26,"phoneExt":26,"email":26},"Ananna Mallik, MD Resident","PRINCIPAL_INVESTIGATOR",{"type":62,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Kazi Mahzabin Arin","Assistant Professor, Department of Anaesthesia, Analgesia and Intensive Care Medicine","100627653","phase-4-efficacy-and-safety-of-mirogabalin-in-diabetic-peripheral-neuropathic-pain-100627653",false,"NCT07451431","Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain","Efficacy, Safety and Patient-Reported Outcomes of Mirogabalin in Diabetic Peripheral Neuropathic Pain","Inclusion Criteria:\n\n* Adults (≥40 years) with diabetic neuropathy (Toronto score ≥6).\n* Persistent pain (NPS) despite standard therapy.\n* Stable diabetes management (HbA1c ≤8.5%).\n\nExclusion Criteria:\n\n* History of drug allergy to gabapentinoids.\n* Concurrent use of opioids or other neuropathic pain medications.\n* Pregnancy or lactation.\n* Cancer pain\n* Entraptment Radioculopathy","ALL","40 Years",{"count":76,"type":77},78,"ESTIMATED","INTERVENTIONAL",[80],"PHASE4","The goal of this clinical trial is to learn if drug Mirogabalin works to treat diabetic peripheral neuropathic pain in adults. It will also learn about the safety of the drug Mirogabalin. The main questions it aims to answer are:\n\nDoes drug mirogabalin reduce neuropathic pain intensity? Is the drug mirogabalin safe in patients with diabetes suffering from neuropathic pain? Does drug mirogabalin improve patients' quality of life (QoL) ( physical, mental, and social well-being)? Researchers will compare drug mirogabalin to drug pregabalin (a drug conventionally used to treat diabetic neuropathic pain) to see if drug mirogabalin works to treat, safe and improve quality of life (QoL) in diabetic neuropathic pain.\n\nParticipants will:\n\nTake drug Mirogabalin or pregabalin every day for 8 weeks Visit the clinic at 1, 2, 4, 6, 8 weeks for checkups",[83],"Diabetic Peripheral Neuropathic Pain (DPNP)",[23,85,86,87],"Diabetic Peripheral Neuropathic Pain","Safety","Efficacy","2026-03-06",{"date":90,"type":91},"2026-03-09","ACTUAL",{"date":93,"type":91},"2025-10-01",{"date":95,"type":77},"2027-05",{"name":5,"class":6},1]